Chimin(SH:603222) Zheng Quan Shi Bao·2025-09-05 11:29Group 1 - Jimin Health (603222) experienced a decline of 8.77% on the trading day, with a turnover rate of 17.07% and a transaction amount of 949.7 million yuan, showing a fluctuation of 7.12% [1] - The stock was listed on the Shanghai Stock Exchange's watch list due to a daily price deviation of -10.01%, with a total net sell of 76.36 million yuan from brokerage seats [1] - Over the past six months, the stock has appeared on the watch list 11 times, with an average price increase of 1.50% the day after being listed and an average increase of 5.91% over the following five days [1] Group 2 - As of September 4, the latest margin trading balance for the stock was 16.9 million yuan, with a financing balance of 16.9 million yuan and a securities lending balance of 91,000 yuan [2] - In the past five days, the financing balance decreased by 73.94 million yuan, representing a decline of 30.40%, while the securities lending balance increased by 7,890 yuan, showing a growth of 649.41% [2] - The company reported a revenue of 366 million yuan for the first half of the year, a year-on-year decrease of 21.30%, and a net profit of -52.7 million yuan [2] Group 3 - On September 5, the top five buying brokerage seats included Guosen Securities (Shenzhen) with a purchase amount of 10.28 million yuan, while the top selling brokerage was Guotai Junan Securities with a selling amount of 41.93 million yuan [3] - The second and third largest buying brokerage seats were Dongguan Securities (Nanjing) and Guosen Securities (Zhejiang), with purchase amounts of 9.59 million yuan and 9.50 million yuan respectively [3] - The second and third largest selling brokerage seats were Zhongtai Securities (Hubei) and Zhongtai Securities (Changzhou), with selling amounts of 25.79 million yuan and 19.53 million yuan respectively [3]